GSK begins COVID-19 vaccine trial with Clover
Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End
The right way to breathe during the coronavirus pandemic
Fighting the COVID-19 pandemic through testing
UK’s Imperial College begins trial of coronavirus vaccine
Fast COVID-19 vaccine timelines are unrealistic and put the integrity of scientists at risk
COVID-19 vaccine to be tested in UIC clinical trial
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Houston "On The Precipice Of Disaster" As Officials Weigh Reimposing Stay At Home Order Amid Spike In Cases: Live Updates
To help West Virginia reopen safely, WVU researchers develop new COVID-19 tests
Lilly announces CNS tie-up with UK biotech Evox Therapeutics
Idexx Unit Gets European Union Regulatory Nod For Covid-19 Test Kit
iBio – IBIO-201
Sorrento Therapeutics and Mount Sinai Health System
Moderna's (MRNA) Stock Will Surge 80% From Current Levels, Says Analyst
Codiak BioSciences and the Ragon Institute of MGH, MIT, and Harvard
Scientists aim gene-targeting breakthrough against COVID-19
Compare the flu pandemic of 1918 and COVID-19 with caution – the past is not a prediction
AstraZeneca Partners With Accent To Develop Novel Cancer Treatments
Chimeron Bio & George Mason NCBID partner on COVID-19 vaccine using ChaESARTM technology
Atriva takes MEK inhibitor into phase 2 for COVID-19
COVID-19 Mouse CRISPR Engineered to Recapitulate Human COVID-19
Vaxine and Medytox – COVAX-19®
Battling disease with ultraviolet light
Merck Takes 3 Major Shots at COVID-19
These are some of the coronavirus vaccine candidates
3 "Strong Buy" Penny Stocks With Triple-Digit Upside
New study to assess the efficacy of ivermectin against COVID-19
Moderna’s Covid-19 Vaccine Candidate Gets FDA Fast Track Status
Researchers testing northern Arizona wastewater for early warning of COVID-19 outbreaks